Voruciclib
Voruciclib is an orally active and selective CDK inhibitor with Ki values of 0.626 nM-9.1 nM. Voruciclib potently blocks CDK9, the transcriptional regulator of MCL-1. Voruciclib represses expression of MCL-1 in multiple models of diffuse large B-cell lymphoma (DLBCL) [1].
Product Specifications
CAS Number
1000023-04-0
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/voruciclib.html
Purity
99.77
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C1C=C(C2=CC=C(C(F)(F)F)C=C2Cl)OC3=C([C@H]4[C@H](CO)N(C)CC4)C(O)=CC(O)=C13
Molecular Formula
C22H19ClF3NO5
Molecular Weight
469.84
Precautions
H302, H315, H319, H335
References & Citations
[1]Dey J, et al. Voruciclib, a clinical stage oral CDK9 inhibitor, represses MCL-1 and sensitizes high-risk Diffuse Large B-cell Lymphoma to BCL2 inhibition. Sci Rep. 2017 Dec 21;7 (1) :18007.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Isoform
CDK1; CDK4; CDK6; CDK9
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
15580126 3x 1.0µg DNA
CD9 CRISPRa sgRNA lentivector (set of three targets)(Rat)
Sign In for Pricing
View Details 
MBS2132411-01 0.1 mL
PE Linked Polyclonal Antibody to Cytochrome P450 3A2 (CYP3A2)
Sign In for Pricing
View Details MBS2132411-02 0.2 mL
PE Linked Polyclonal Antibody to Cytochrome P450 3A2 (CYP3A2)
Sign In for Pricing
View Details MBS2132411-03 0.5 mL
PE Linked Polyclonal Antibody to Cytochrome P450 3A2 (CYP3A2)
Sign In for Pricing
View Details MBS2132411-04 1 mL
PE Linked Polyclonal Antibody to Cytochrome P450 3A2 (CYP3A2)
Sign In for Pricing
View Details